首页> 美国卫生研究院文献>other >A Method Enabling High-Throughput Sequencing of Human Cytomegalovirus Complete Genomes from Clinical Isolates
【2h】

A Method Enabling High-Throughput Sequencing of Human Cytomegalovirus Complete Genomes from Clinical Isolates

机译:从临床分离株中实现人巨细胞病毒完整基因组高通量测序的方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Human cytomegalovirus (HCMV) is a ubiquitous virus that can cause serious sequelae in immunocompromised patients and in the developing fetus. The coding capacity of the 235 kbp genome is still incompletely understood, and there is a pressing need to characterize genomic contents in clinical isolates. In this study, a procedure for the high-throughput generation of full genome consensus sequences from clinical HCMV isolates is presented. This method relies on low number passaging of clinical isolates on human fibroblasts, followed by digestion of cellular DNA and purification of viral DNA. After multiple displacement amplification, highly pure viral DNA is generated. These extracts are suitable for high-throughput next-generation sequencing and assembly of consensus sequences. Throughout a series of validation experiments, we showed that the workflow reproducibly generated consensus sequences representative for the virus population present in the original clinical material. Additionally, the performance of 454 GS FLX and/or Illumina Genome Analyzer datasets in consensus sequence deduction was evaluated. Based on assembly performance data, the Illumina Genome Analyzer was the platform of choice in the presented workflow. Analysis of the consensus sequences derived in this study confirmed the presence of gene-disrupting mutations in clinical HCMV isolates independent from in vitro passaging. These mutations were identified in genes RL5A, UL1, UL9, UL111A and UL150. In conclusion, the presented workflow provides opportunities for high-throughput characterization of complete HCMV genomes that could deliver new insights into HCMV coding capacity and genetic determinants of viral tropism and pathogenicity.
机译:人巨细胞病毒(HCMV)是一种普遍存在的病毒,可在免疫功能低下的患者和发育中的胎儿中引起严重的后遗症。 235kbp基因组的编码能力仍未完全理解,迫切需要表征临床分离物中的基因组含量。在这项研究中,提出了从临床HCMV分离株高通量生成全基因组共有序列的程序。此方法依赖于人类成纤维细胞上临床分离株的低传代率,然后消化细胞DNA和纯化病毒DNA。在多次置换扩增后,产生了高纯度的病毒DNA。这些提取物适用于高通量下一代测序和共有序列的组装。在一系列验证实验中,我们证明了工作流可重复生成代表原始临床材料中存在的病毒种群的共有序列。此外,还评估了454 GS FLX和/或Illumina Genome Analyzer数据集在共有序列推导中的性能。基于装配性能数据,Illumina基因组分析仪是所介绍工作流程中的首选平台。对这项研究中衍生的共有序列的分析证实了独立于体外传代的临床HCMV分离物中存在破坏基因的突变。在基因RL5A,UL1,UL9,UL111A和UL150中鉴定了这些突变。总之,提出的工作流程为完整的HCMV基因组的高通量表征提供了机会,这可以为HCMV编码能力以及病毒嗜性和致病性的遗传决定因素提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号